Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.33%
#3 Black Phoenix Black Phoenix +35.18%
#4 Velvet Velvet +25.69%
#5 Akedo Akedo +22.89%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.03%
#7 DoubleZero DoubleZero +17.26%
#8 Fake World Assets Fake World Assets +16.79%
#9 Palladium Network Palladium Network +14.94%
#10 clBTC clBTC +11.73%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Halberd Corporation Halberd Corporation

Halberd Corporation

HALB
Rank in Stocks #39750
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies... Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
Share Price
$0.0007
Last synced: 2026-08-13
Market Cap
$361.11K
Change (1 day)
-12.50%
Change (1 year)
-63.16%
Country
US
Trade Halberd Corporation (HALB)

Category

Healthcare
Earnings for Halberd Corporation (HALB)
Earnings in 2026 TTM: 0
According to Halberd Corporation latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Halberd Corporation from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE